<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Morisset J</submitter><funding>National Center for Advancing Translational Sciences</funding><funding>NCATS NIH HHS</funding><funding>Nina Ireland Program for Lung Health</funding><pagination>51-56</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5506836</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>127</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is associated with significant morbidity and mortality. Similarities have been observed between patients with idiopathic pulmonary fibrosis (IPF) and the UIP (usual interstitial pneumonia) form of RA-ILD. The GAP (gender, age, physiology) model has been shown to predict mortality in patients with IPF, but its ability to predict mortality in RA-ILD is not known.&lt;h4>Methods&lt;/h4>We identified 309 patients with RA-ILD at 4 academic centers with ongoing longitudinal cohorts of patients with ILD. The primary endpoint was mortality. To handle missing data (n = 219 subjects with complete dataset), multiple imputation by iterative chained equations was used. Using the GAP model as a baseline, we assessed improveme</pubmed_abstract><journal>Respiratory medicine</journal><pubmed_title>The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease.</pubmed_title><pmcid>PMC5506836</pmcid><funding_grant_id>KL2 TR000143</funding_grant_id><funding_grant_id>UCSF-CTI KL2TR000143</funding_grant_id><pubmed_authors>Jones KD</pubmed_authors><pubmed_authors>Lee BY</pubmed_authors><pubmed_authors>Hu X</pubmed_authors><pubmed_authors>King TE</pubmed_authors><pubmed_authors>Gross AJ</pubmed_authors><pubmed_authors>Morisset J</pubmed_authors><pubmed_authors>Tonelli R</pubmed_authors><pubmed_authors>Cerri S</pubmed_authors><pubmed_authors>Manfredi A</pubmed_authors><pubmed_authors>Lee JS</pubmed_authors><pubmed_authors>Kim DS</pubmed_authors><pubmed_authors>Vittinghoff E</pubmed_authors><pubmed_authors>Elicker BM</pubmed_authors><pubmed_authors>Ryu JH</pubmed_authors><pubmed_authors>Ley B</pubmed_authors><pubmed_authors>Wolters PJ</pubmed_authors><pubmed_authors>Collard HR</pubmed_authors><pubmed_authors>Sebastiani M</pubmed_authors></additional><is_claimable>false</is_claimable><name>The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease.</name><description>&lt;h4>Background&lt;/h4>Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is associated with significant morbidity and mortality. Similarities have been observed between patients with idiopathic pulmonary fibrosis (IPF) and the UIP (usual interstitial pneumonia) form of RA-ILD. The GAP (gender, age, physiology) model has been shown to predict mortality in patients with IPF, but its ability to predict mortality in RA-ILD is not known.&lt;h4>Methods&lt;/h4>We identified 309 patients with RA-ILD at 4 academic centers with ongoing longitudinal cohorts of patients with ILD. The primary endpoint was mortality. To handle missing data (n = 219 subjects with complete dataset), multiple imputation by iterative chained equations was used. Using the GAP model as a baseline, we assessed improveme</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Jun</publication><modification>2025-04-04T19:28:28.991Z</modification><creation>2019-03-26T23:38:52Z</creation></dates><accession>S-EPMC5506836</accession><cross_references><pubmed>28502419</pubmed><doi>10.1016/j.rmed.2017.04.012</doi></cross_references></HashMap>